- Home
- JMIA vs SANA Comparison
JMIA vs SANA Comparison
Compare JMIA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JMIA | SANA |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JMIA | SANA |
|---|---|---|
| Price | $12.90 | $4.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $17.00 | $7.83 |
| AVG Volume (30 Days) | ★ 2.7M | 2.5M |
| Earning Date | 02-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $173,224,000.00 | N/A |
| Revenue This Year | $19.93 | N/A |
| Revenue Next Year | $22.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $1.26 |
| 52 Week High | $14.72 | $6.55 |
Technical Indicators
Market Signals| Indicator | JMIA | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 57.00 |
| Support Level | $11.88 | $4.36 |
| Resistance Level | $14.72 | $5.20 |
| Average True Range (ATR) | 0.70 | 0.34 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 35.74 | 69.75 |
Price Performance
Historical ComparisonAbout JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.